2 terminated, 1 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Vrs-317: new trials by email Literature Review of Vrs-317 trials Research Report on Vrs-317
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD) somavaratan - Adult Growth Hormone Deficiency (AGHD) | Phase 2 | Terminated | Versartis Inc. | 36 | 2016-02-11 | 2023-04-13 |
| Versartis International Trial in Adults With Long-Acting Growth Hormone somavaratan - Adult Growth Hormone Deficiency | Phase 2 | Completed | Versartis Inc. | 36 | 2015-07-01 | 2022-07-26 |
| Versartis Long-Term Safety Study of Somavaratan somavaratan - Pediatric Growth Hormone Deficiency | Phase 2 / Phase 3 | Terminated | Versartis Inc. | 385 | 2014-03-03 | 2018-03-09 |
Dwarfism, Pituitary (3) · Dwarfism (1) · Growth Disorders (1)
Versartis Inc. (3)
Australia (1) · Germany (1) · United Kingdom (1) · United States (1)
Will Charlton, MD (2) · Daniela Rogoff, MD, PhD (1)